Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis

NCT02794467 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Study was prematurely discontinued due to GSK's change in prioritization for the portfolio and is not due to any safety concerns or regulatory interaction.

Conditions

Interventions

Sponsor

GlaxoSmithKline